Viewing Study NCT00162851


Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2025-12-25 @ 9:33 PM
Study NCT ID: NCT00162851
Status: COMPLETED
Last Update Posted: 2007-07-25
First Post: 2005-09-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study to Evaluate the Safety of Subcutaneous Alemtuzumab in Patients With B-Cell Chronic Lymphocytic Leukemia
Sponsor: Karolinska University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module